MG01CI
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MG01CI, covering 2014-01-14 to 2017-03-28. Get the full timeline:
Most recent: Clinical Trial Update: A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) [Phase 2, Phase 3]